C06OD034125
Project Grant
Overview
Grant Description
Developing the VUMC micro facility to advance innovative BSL3 research.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Nashville,
Tennessee
37203
United States
Geographic Scope
Single Zip Code
Related Opportunity
Vanderbilt University Medical Center was awarded
Advancing Innovative BSL3 Research: VUMC Micro Facility Development
Project Grant C06OD034125
worth $7,975,000
from the National Institute of Allergy and Infectious Diseases in September 2022 with work to be completed primarily in Nashville Tennessee United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.352 Construction Support.
The Project Grant was awarded through grant opportunity Biomedical Research Facilities (C06 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 5/20/24
Period of Performance
9/16/22
Start Date
5/31/27
End Date
Funding Split
$8.0M
Federal Obligation
$0.0
Non-Federal Obligation
$8.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to C06OD034125
Additional Detail
Award ID FAIN
C06OD034125
SAI Number
C06OD034125-1923510636
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75AGNA NIH AGGREGATE FINANCIAL ASSISTANCE DATA AWARDING OFFICE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
GYLUH9UXHDX5
Awardee CAGE
7HUA5
Performance District
TN-05
Senators
Marsha Blackburn
Bill Hagerty
Bill Hagerty
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $7,975,000 | 100% |
Modified: 5/20/24